Ausgabe 1/2014
Inhalt (7 Artikel)
Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
Wolfgang Mueck, Jan Stampfuss, Dagmar Kubitza, Michael Becka
Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2
Sreeneeranj Kasichayanula, Xiaoni Liu, Frank LaCreta, Steven C. Griffen, David W. Boulton
Pharmacokinetic of Antiepileptic Drugs in Patients with Hepatic or Renal Impairment
Gail D. Anderson, Shahin Hakimian
A Mechanistic Framework for In Vitro–In Vivo Extrapolation of Liver Membrane Transporters: Prediction of Drug–Drug Interaction Between Rosuvastatin and Cyclosporine
M. Jamei, F. Bajot, S. Neuhoff, Z. Barter, J. Yang, A. Rostami-Hodjegan, K. Rowland-Yeo
Development of a Paediatric Population-Based Model of the Pharmacokinetics of Rivaroxaban
Stefan Willmann, Corina Becker, Rolf Burghaus, Katrin Coboeken, Andrea Edginton, Jörg Lippert, Hans-Ulrich Siegmund, Kirstin Thelen, Wolfgang Mück
The Effect of St John’s Wort on the Pharmacokinetics of Docetaxel
Andrew K. L. Goey, Irma Meijerman, Hilde Rosing, Serena Marchetti, Marja Mergui-Roelvink, Marianne Keessen, Jacobus A. Burgers, Jos H. Beijnen, Jan H. M. Schellens